Position in A
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,074,560
-$9,162,371 QoQ
Shares Held
184,897
-16.8% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
1.39%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Meridiem Capital Partners LP holds $214,886,909 across 8 Diagnostics & Research names. A ranks #4 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
362,098 | $62,461,905 | |
| 2 | WAT |
Waters Corp /De/
|
207,814 | $61,887,009 | |
| 3 | ILMN |
Illumina, Inc.
|
313,272 | $38,613,906 | |
| 4 | A |
Agilent Technologies, Inc.
This page
|
184,897 | $21,074,560 | |
| 5 | TWST |
Twist Bioscience Corp
|
239,669 | $11,389,070 | |
| 6 | ICLR |
Icon PLC
|
93,878 | $10,388,539 | |
| 7 | CDNA |
CareDx, Inc.
|
316,950 | $5,502,252 | |
| 8 | WGS |
GeneDx Holdings Corp.
|
55,585 | $3,569,668 |
All Filings in A
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,074,560 | 184,897 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,236,931 | 222,216 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $25,638,262 | 217,255 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $20,611,876 | 176,200 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $29,491,660 | 219,530 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||